Specificity of signaling by hematopoietic cytokine receptors: Instructive versus permissive effects

Journal of Receptor and Signal Transduction Research

Volumn 19, Issue 1-4, 1999, Pages 741-772

  Skoda, Radek C ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; PROTEIN TYROSINE KINASE;

CONFERENCE PAPER; ENZYME ACTIVATION; HEMATOPOIESIS; HEMATOPOIETIC CELL; MOLECULAR DYNAMICS; PROTEIN FAMILY; REACTION ANALYSIS; RECEPTOR AFFINITY; RECEPTOR BINDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

JANUS;

EID: 0032993306     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899909036684     Document Type: Conference Paper

References (163)

1. Bazan, J.F. Haemopoietic receptors and helical cytokines. Immunol. Today 11, 350-354, 1990.
2. Rozwarski, D.A.; Gronenborn, A.M.; Clore, G.M.; Bazan, J.F.; Bohm, A.; Wlodawer, A.; Hatada, M.; and Karplus, P.A. Structural comparisons among the short-chain helical cytokines. Structure 2, 159-173, 1994.
3. Bazan, J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Nat.l Acad. Sci. USA 87, 6934-6938, 1990.
4. Wells, J.A.; and de Vos, A.M. Hematopoietic receptor complexes. Annu. Rev. Biochem. 65, 609-634, 1996.
5. de Vos, A.; Ultsch, M.; and Kossiakoff, A.A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255, 306-312, 1992.
6. Donahue, L.R.; and Beamer, W.G. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. J. Endocrinol. 136, 91-104, 1993.
7. Horseman, N.D.; Zhao, W.; Montecino-Rodriguez, E.; Tanaka, M.; Nakashima, K.; Engle, S.J.; Smith, F.; Markoff, E.; and Dorshkind, K. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 16, 6926-6935, 1997.
8. Wu, H.; Liu, X.; Jaenisch, R.; and Lodish, H.F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83, 59-67, 1995.
9. de Sauvage, F.J.; Carver-Moore, K.; Luoh, S.M.; Ryan, A.; Dowd, M.; Eaton, D.L.; and Moore, M.W. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J. Exp. Med. 183, 651-656, 1996.
10. Lantz, C.S.; Boesiger, J.; Song, C.H.; Mach, N.; Kobayashi, T.; Mulligan, R.C.; Nawa, Y.; Dranoff, G.; and Galli, S.J. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392, 90-93, 1998.
11. Kopf, M.; Brombacher, F.; Hodgkin, P.D.; Ramsay, A.J.; Milbourne, E.A.; Dai, W.J.; Ovington, K.S.; Behm, C.A.; Kohler, G.; Young, I.G.; and Matthaei, K.I. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4, 15-24, 1996.
12. Dranoff, G.; Crawford, A.d.; Sadelain, M.; Ream, B.; Rashid, a.; Bronson, R.T.; Dickersin, G.R.; Bachurski, C.J.; Mark, E.L.; Whitsett, J.A.; and Mulligan, R.C. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 364, 713-716, 1994.
13. Kopf, M.; Baumann, H.; Freer, G.; Freudenberg, M.; Lamers, M.; Kishimoto, T.; Zinkernagel, R.; Bluethmann, H.; and Kohler, G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339-342, 1994.
14. Poli, V.; Balena, R.; Fattori, E.; Markatos, A.; Yamamoto, M.; Tanaka, H.; Ciliberto, G.; Rodan, G.A.; and Costantini, F. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13, 1189-1196, 1994.
15. Stewart, C.L.; Kaspar, P.; Brunet, L.J.; Bhatt, H.; Gadi, I.; Königen, F.; and Abbondanzo, S. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 359, 76-79, 1992.
16. Escary, J.L.; Perreau, J.; Dumenil, D.; Ezine, S.; and Brulet, P. Leukemia inhibitory factor is necessary for maintenance of hematopoietic stem cells and thymocyte stimulation. Nature 363, 361-364, 1993.
17. Masu, Y.; Wolf, E.; Holtmann, B.; Sendtner, M.; Brem, G.; and Thoenen, H. Disruption of the CNTF gene results in moter neuron degeneration. Nature 365, 27-32, 1993.
18. Lieschke, G.J.; Grail, D.; Hodgson, G.; Metcalf, D.; Stanley, E.; Cheers, C.; Fowler, K.J.; Basu, S.; Zhan, Y.F.; and Dunn, A.R. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84, 1737-1746, 1994.
19. Mattner, F.; Magram, J.; Ferrante, J.; Launois, P.; Di Padova, K.; Behin, R.; Gately, M.K.; Louis, J.A.; and Alber, G. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26, 1553-1559, 1996.
20. Ingalls, A.M.; Dickie, M.M.; and Snell, G.D. Obese, a new mutation in the house mouse. J. Hered. 41, 317-318, 1950.
21. Coleman, D.L. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14, 141-148, 1978.
22. Zhang, Y.; Proenca, R.; Maffei, M.; Barone, M.; Leopold, L.; and Friedman, J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432, 1994.
23. Schorle, H.; Holtschke, T.; Hunig, T.; Schimpl, A.; and Horak, I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352, 621-624, 1991.
24. Kuhn, R.; Rajewsky, K.; and Muller, W. Generation and analysis of interleukin-4 deficient mice. Science 254, 707-710, 1991.
25. Kopf, M.; Le, G.-G.; Bachmann, M.; Lamers, M.C.; Bluethmann, H.; and Kohler, G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362, 245-248, 1993.
26. von Freeden-Jeffry, U.; Vieira, P.; Lucian, L.A.; McNeil, T.; Burdach, S.E.; and Murray, R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181, 1519-1526, 1995.
27. Dalton, D.K.; Pitts-Meek, S.; Keshav, S.; Figari, I.S.; Bradley, A.; and Stewart, T.A. Multiple defects of immune cells in mice with disrupted interferon-gamma genes. Science 259, 1739-1742, 1993.
28. Kuhn, R.; Lohler, J.; Rennick, D.; Rajewsky, K.; and Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274, 1993.
29. Leung, D.W.; Spencer, S.A.; Cachianes, G.; Hammonds, R.G.; Collins, C.; Henzel, W.J.; Barnard, R.; Waters, M.J.; and Wood, W.I. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330, 537-543, 1987.
30. Duquesnoy, P.; Sobrier, M.L.; Amselem, S.; and Goossens, M. Defective membrane expression of human growth hormone (GH) receptor causes Laron-type GH insensitivity syndrome. Proc. Natl. Acad. Sci. U.S.A. 88, 10272-10276, 1991.
31. Zhou, Y.; Xu, B.C.; Maheshwari, H.G.; He, L.; Reed, M.; Lozykowski, M.; Okada, S.; Cataldo, L.; Coschigamo, K.; Wagner, T.E.; Baumann, G.; and Kopchick, J.J. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc. Natl. Acad. Sci. U.S.A. 94, 13215-21320, 1997.
32. Boutin, J.M.; Jolicoeur, C.; Okamura, H.; Gagnon, J.; Edery, M.; Shirota, M.; Banville, D.; Dusanter-Fourt, I.; Djiane, J.; and Kelly, P.A. Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor family. Cell, 69-77, 1988.
33. Moore, R.C.; and Oka, T. Cloning and sequencing of the cDNA encoding the murine mammary gland long-form prolactin receptor. Gene 134, 263-265, 1993.
34. Ormandy, C.J.; Camus, A.; Barra, J.; Damotte, D.; Lucas, B.; Buteau, H.; Edery, M.; Brousse, N.; Babinet, C.; Binart, N.; and Kelly, P.A. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11, 167-178, 1997.
35. D'Andrea, A.D.; Lodish, H.F.; and Wong, G.G. Expression cloning of the murine erythropoietin receptor. Cell 57, 277-285, 1989.
36. Lin, C.S.; Lim, S.K.; D'Agati, V.; and Constantini, F. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev 10, 154-164, 1996.
37. Kieran, M.W.; Perkins, A.C.; Orkin, S.H.; and Zon, L.I. Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor. Proc. Natl. Acad. Sci. U.S.A. 93, 9126-9131, 1996.
38. Vigon, I.; Mornon, J.P.; Cocault, L.; Mitjavila, M.T.; Tambourin, P.; Gisselbrecht, S.; and Souyri, M. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc. Natl. Acad. Sci. U.S.A. 89, 5640-5644, 1992.
39. Skoda, R.C.; Seldin, D.C.; Chiang, M.K.; Peichel, C.L.; Vogt, T.F.; and Leder, P. Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. EMBO J. 12, 2645-2653, 1993.
40. Vigon, I.; Florindo, C.; Fichelson, S.; Guenet, J.L.; Mattei, M.G.; Souyri, M.; Cosman, D.; and Gisselbrecht, S. Characterization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth. Oncogene 8, 2607-2615, 1993.
41. Gurney, A.L.; Carver-Moore, K.; de Sauvage, F.J.; and Moore, M.W. Thrombocytopenia in c-mpl-deficient mice. Science 265, 1445-1447, 1994.
42. Alexander, W.S.; Roberts, A.W.; Nicola, N.A.; Li, R.L.; and Metcalf, D. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-mpl. Blood 87, 2162-2170, 1996.
43. Gorman, D.M.; Itoh, N.; Kitamura, T.; Schreurs, J.; Yonehara, S.; Yahara, I.; Arai, K.; and Miyajima, A. Cloning and expression of a gene encoding an interleukin 3 receptor-like protein: identification of another member of the cytokine receptor gene family. Proc. Natl. Acad. Sci. U.S.A. 87, 5459-5463, 1990.
44. Robb, L.; Drinkwater, C.C.; Metcalf, D.; Li, R.; Kontgen, F.; Nicola, N.A.; and Begley, C.G. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc. Natl. Acad. Sci. U.S.A. 92, 9565-9569, 1995.
45. Itoh, N.; Yonehara, S.; Schreurs, J.; Gorman, D.M.; Maruyama, K.; Ishii, A.; Yahara, I.; Arai, K.; and Miyajima, A. Cloning of an interleukin-3 receptor gene: a member of a distinct receptor gene family. Science 247, 324-327, 1990.
46. Nicola, N.; Robb, L.; Metcalf, D.; Cary, D.; Drinkwater, C.C.; and Begley, C.G. Functional inactivation in mice of the gene for the interleukin-3 (IL-3)-specific receptor β-chain: Implications for IL-3 function and the mechanism of receptor transmodulation in hematopoietic cells. Blood 87, 2665-2674, 1996.
47. Ichihara, M.; Hara, T.; Takagi, M.; Cho, L.C.; Gorman, D.M.; and Miyajima, A. Impaired interleukin-3 (IL-3) response of the A/J mouse is caused by a branch point deletion in the IL-3 receptor alpha subunit gene. EMBOJ. 14, 939-950, 1995.
48. Hara, T.; Ichihara, M.; Takagi, M.; and Miyajima, A. Interleukin-3 (IL-3) poor-responsive inbred mouse strains carry the identical deletion of a branch point in the IL-3 receptor alpha subunit gene. Blood 85, 2331-2336, 1995.
49. Takaki, S.; Tominaga, A.; Hitoshi, H.; Mita, S.; Sonoda, E.; Yamaguchi, N.; and Takatsu, K. Molecular cloning and expression of the murine interleukin-5 receptor. EMBO J. 9, 4367-4374, 1990.
50. Yoshida, T.; Ikuta, K.; Sugaya, H.; Maki, K.; Takagi, M.; Kanazawa, H.; Sunaga, S.; Kinashi, T.; Yoshimura, K.; Miyazaki, J.; Takaki, S.; and Takatsu, K. Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. Immunity 4, 483-494, 1996.
51. Park, L.S.; Martin, U.; Sorensen, R.; Luhr, S.; Morrissey, P.J.; Cosman, D.; and Larsen, A. Cloning of the low-affinity murine granulocyte-macrophage colony-stimulating factor receptor and reconstitution of a high-affinity receptor complex. Proc. Natl. Acad. Sci. U.S.A. 89, 4295-4299, 1992.
52. Hibi, M.; Murakami, M.; Saito, M.; Hirano, T.; Taga, T.; and Kishimoto, T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63, 1149-1157, 1990.
53. Saito, M.; Yoshida, K.; Hibi, M.; Taga, T.; and Kishimoto, T. Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. J. Immunol. 148, 4066-4071, 1992.
54. Yoshida, K.; Taga, T.; Saito, M.; Suematsu, S.; Kumanogoh, A.; Tanaka, T.; Fujiwara, H.; Hirata, M.; Yamagami, T.; Nakahata, T.; Hirabayashi, T.; Yoneda, Y.; Tanaka, K.; Wang, W.Z.; Mori, C.; Shiota, K.; Yoshida, N.; and Kishimoto, T. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. U.S.A. 93, 407-411, 1996.
55. Yamasaki, K.; Taga, T.; Hirata, Y.; Yawata, H.; Kawanishi, Y.; Seed, B.; Taniguchi, T.; Hirano, T.; and Kishimoto, T. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science 241, 825-828, 1988.
56. Sugita, T.; Totsuka, T.; Saito, M.; Yamasaki, K.; Taga, T.; Hirano, T.; and Kishimoto, T. Functional murine interleukin 6 receptor with the intracisternal A particle gene product at its cytoplasmic domain. Its possible role in plasmacytomagenesis. J. Exp. Med. 171, 2001-2009, 1990.
57. Hilton, D.J.; Hilton, A.A.; Raicevic, A.; Rakar, S.; Harrison-Smith, M.; Gough, N.M.; Begley, C.G.; Metcalf, D.; Nicola, N.A.; and Willson, T.A. Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 13, 4765-4775, 1994.
58. Neuhaus, H.; Bettenhausen, B.; Bilinski, P.; Simon-Chazottes, D.; Guenet, J.L.; and Gossler, A. Etl2, a novel putative type-I cytokine receptor expressed during mouse embryogenesis at high levels in skin and cells with skeletogenic potential. Developmental Biology 166, 531-542, 1994.
59. Gearing, D.P.; Thut, C.J.; VandeBos, T.; Gimpel, S.D.; Delaney, P.B.; King, J.; Price, V.; Cosman, D.; and Beckmann, M.P. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBOJ. 10, 2839-2848, 1991.
60. Ware, C.B.; Horowitz, M.C.; Renshaw, B.R.; Hunt, J.S.; Liggitt, D.; Koblar, S.A.; Gliniak, B.C.; McKenna, H.J.; Papayannopoulou, T.; Thoma, B.; Cheng, L.; Donovan, P.J.; Peschon, J.J.; Bartlett, P.P.; Willis, C.R.; Wright, B.D.; Carpenter, M.K.; Davison, B.L.; and Gearing, D.P. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121, 1283-1299, 1995.
61. Mosley, B.; De Imus, C.; Friend, D.; Boiani, N.; Thoma, B.; Park, L.S.; and Cosman, D. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J. Biol. Chem. 271, 32635-32643, 1996.
62. Lindberg, R.A.; Juan, T.S.; Welcher, A.A.; Sun, Y.; Cupples, R.; Guthrie, B.; and Fletcher, F.A. Cloning and characterization of a specific receptor for mouse oncostatin M. Mol. Cell. Biol. 18, 3357-3367, 1998.
63. Davis, S.; Aldrich, T.H.; Valenzuela, D.M.; Wong, V.V.; Furth, M.E.; Squinto, S.P.; and Yancopoulos, G.D. The receptor for ciliary neurotrophic factor. Science 253, 59-63, 1991.
64. DeChiara, T.; Vejsada, R.; Poueymirou, W.T.; Acheson, A.; Suri, C.; Conover, J.C.; Friedman, B.; McClain, J.; Pan, L.; Stahl, N.; Ip, N.Y.; Kato, A.; and Yancopoulos, G.D. Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 83, 313-322, 1995.
65. Fukunaga, R.; Ishizaka, I.E.; Seto, Y.; and Nagata, S. Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell 61, 341-350, 1990.
66. Liu, F.; Wu, H.Y.; Wesselschmidt, R.; Kornaga, T.; and Link, D.C. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5, 491-501, 1996.
67. Liu, F.; Poursine-Laurent, J.; and Link, D.C. The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not flt-3 ligand. Blood 90, 2522-2528, 1997.
68. Chua, A.O.; Chizzonite, R.; Desai, B.B.; Truitt, T.P.; Nunes, P.; Minetti, L.J.; Warrier, R.R.; Presky, D.H.; Levine, J.F.; Gately, M.K.; and U., G. Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J. Immunol. 153, 128-136, 1994.
69. Gubler, U.; Chua, A.O.; Schoenhaut, D.S.; Dwyer, C.M.; McComas, W.; Motyka, R.; Nabavi, N.; Wolitzky, A.G.; Quinn, P.M.; Familletti, P.C.; and Gately, M.K. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. U.S.A. 88, 4143-4147, 1991.
70. Magram, J.; Connaughton, S.E.; Warrier, R.R.; Carvajal, D.M.; Wu, C.-Y.; Ferrante, J.; Stewart, C.; Sarmiento, U.; Faherty, D.A.; and Gately, M.K. IL-12-Deficient Mice Are Defective in IFN Production and Type 1 Cytokine Responses. Immunity 4, 471-481, 1996.
71. Wu, C.; Ferrante, J.; Gately, M.K.; and Magram, J. Characterization of IL-12 receptor betal chain (IL-12Rbetal)-deficient mice: IL-12Rbetal is an essential component of the functional mouse IL- 12 receptor. J. Immunol. 159, 1658-1665, 1997.
72. de Jong, R.; Altare, F.; Haagen, I.A.; Elferink, D.G.; Boer, T.; van Breda Vriesman, P.J.; Kabel, P.J.; Draaisma, J.M.; van Dissel, J.T.; Kroon, F.P.; Casanova, J.L.; and Ottenhoff, T.H. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280, 1435-1438, 1998.
73. Tartaglia, L.A.; Dembski, M.; Weng, X.; Deng, N.; Culpepper, J.; Devos, R.; Richards, G.J.; Campfield, L.A.; Clark, F.T.; Deeds, J.; Muir, C.; Sanker, S.; Moriarty, A.; Moore, K.J.; Smutko, J.S.; Mays, G.G.; Woolf, E.A.; Monroe, C.A.; and Tepper, R.I. Identification and expression cloning of a leptin receptor, OR-R. Cell 83, 1263-1271, 1995.
74. Lee, G.H.; Proenca, R.; Montez, J.M.; Carroll, K.M.; Darvishzadeh, J.G.; Lee, J.I.; and Friedman, J.M. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379, 632-635, 1996.
75. Chen, H.; Charlat, O.; Tartaglia, L.A.; Woolf, E.A.; Weng, X.; Ellis, S.J.; Lakey, N.D.; Culpepper, J.; Moore, K.J.; Breitbart, R.E.; Duyk, G.M.; Tepper, R.I.; and Morgenstern, J.P. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84, 481-495, 1996.
76. Takeshita, T.; Asao, H.; Ohtani, K.; Ishii, N.; Kumaki, S.; Tanaka, N.; Munakata, H.; Nakamura, M.; and Sugamura, K. Cloning of the gamma chain of the human IL-2 receptor. Science 257, 379-382, 1992.
77. Cao, X.; Kozak, C.A.; Liu, Y.J.; Noguchi, M.; O'Connell, E.; and Leonard, W.J. Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) gamma chain: chromosomal mapping and tissue specificity of IL-2R gamma chain expression. Proc. Natl. Acad. Sci. U.S.A. 90, 8464-8468, 1993.
78. Noguchi, M.; Yi, H.; Rosenblatt, H.M.; Filipovich, A.H.; Adelstein, S.; Modi, W.S.; McBride, O.W.; and Leonard, W.J. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73, 147-157, 1993.
79. DiSanto, J.P.; Muller, W.; Guy-Grand, D.; Fischer, A.; and Rajewsky, K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc. Natl. Acad. Sci. U.S.A. 92, 377-381, 1995.
80. Kono, T.; Doi, T.; Yamada, G.; Hatakeyama, M.; Minamoto, S.; Tsudo, M.R.A.; Miyasaka, M.; Miyata, T.; and Taniguchi, T. Murine interleukin-2 receptor β-chain: Dysregulated gene expression in lymphoma line EL-4 caused by a promoter insertion. Proc. Natl. Acad. Sci. U.S.A. 87, 1806-1810, 1990.
81. Suzuki, H.; Duncan, G.S.; Takimoto, H.; and Mak, T.W. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. J. Exp. Med. 185, 499-505, 1997.
82. Mosley, B.; Beckmann, M.P.; March, C,J.; Idzerda, R.L.; Gimpel, S.D.; VandenBos, T.; Friend, D.; Alpert, A.; Anderson, D.; Jackson, J.; Wignall, J.M.; Smith, C.; Gallis, B.; Simms, I.E.; Urdall, D.; Widmer, M.B.; Cosman, D.; and Park, L.S. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 59, 335-348, 1989.
83. Barner, M.; Mohrs, M.; Brombacher, F.; and Kopf, M. Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr. Biol. 8, 669-672, 1998.
84. Goodwin, R.G.; Friend, D.; Ziegler, S.F.; Jerzy, R.; Falk, B.A.; Gimpel, S.; Cosman, D.; Dower, S.K.; March, C.J.; Namen, A.E.; and et, a.l. Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell 60, 941-951, 1990.
85. Peschon, J.J.; Morrissey, P.J.; Grabstein, K.H.; Ramsdell, F.J.; Maraskovsky, E.; Gliniak, B.C.; Park, L.S.; Ziegler, S.F.; Williams, D.E.; and Ware, C.B. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955-1960, 1994.
86. Maki, K.; Sunaga, S.; Komagata, Y.; Kodaira, Y.; Mabuchi, A.; Karasuyama, H.; Yokomuro, K.; Miyazaki, J.I.; and Ikuta, K. Interleukin 7 receptor-deficient mice lack gamma delta T cells. Proc. Natl. Acad. Sci. U.S.A. 93, 7172-7177, 1996.
87. Ward, L.D.; Howlett, G.J.; Discolo, G.; Yasukawa, K.; Hammacher, A.; Moritz, R.L.; and Simpson, R.J. High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. J. Biol. Chem. 269, 23286-23289, 1994.
88. Hilton, D.J.; Zhang, J.G.; Metcalf, D.; Alexander, W.S.; Nicola, N.A.; and Willson, T. A. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. U.S.A. 93, 497-501, 1996.
89. Uze, G.; Lutfalla, G.; and Gresser, I. Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 60, 225-234, 1990.
90. Hwang, S.Y.; Hertzog, P.J.; Holland, K.A.; Sumarsono, S.H.; Tymms, M.J.; Hamilton, J.A.; Whitty, G.; Bertoncello, I.; and Kola, I. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc. Natl. Acad. Sci. U.S.A. 92, 11284-88, 1995.
91. Novick, D.; Cohen, B.; and Rubinstein, M. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 77, 391-400, 1994.
92. Novick, D.; Cohen, B.; Tal, N.; and Rubinstein, M. Soluble and membrane-anchored forms of the human IFN-alpha/beta receptor. J Leukoc. Biol. 57, 712-718, 1995.
93. Aguet, M.; Dembic, Z.; and Merlin, G. Molecular cloning and expression of the human interferon-gamma receptor. Cell 55, 273-280, 1988.
94. Huang, S.; Hendricks, W.; Althage, A.; Hemmi, S.; Bluethmann, H.; Kamijo, R.; Vilcek, J.; Zinkernagel, R.M.; and Aguet, M. Immune response in mice that lack the interferon-gamma receptor. Science 259, 1742-1745, 1993.
95. Hemmi, S.; Bohni, R.; Stark, G.; DiMarco, F.; and Aguet, M. A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in human cells. Cell 76, 803-810, 1994.
96. Soh, J.; Donnelly, R.J.; Kotenko, S.; Mariano, T.M.; Cook, J.R.; Wang, N.; Emanuel, S.; Schwartz, B.; Miki, T.; and Pestka, S. Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor. Cell 76, 793-802, 1994.
97. Ho, A.S.; Liu, Y.; Khan, T.A.; Hsu, D.H.; Bazan, J.F.; and Moore, K.W. A receptor for interleukin 10 is related to Interferon receptors. Proc. Natl. Acad. Sci. U.S.A. 90, 11267-11271, 1993.
98. Muller, Y.A.; Ultsch, M.H.; and de Vos, A.M. The crystal structure of the extracellular domain of human tissue factor refined to 1.7 A resolution. J. Mol. Biol. 256, 144-159, 1996.
99. Carmeliet, P.; Mackman, N.; Moons, L.; Luther, T.; Gressens, P.; Van Vlaenderen, I.; Demunck, H.; Kasper, M.; Breier, G.; Evrard, P.; Muller, M.; Risau, W.; Edgington, T.; and Collen, D. Role of tissue factor in embryonic blood vessel development. Nature 383, 73-75, 1996.
100. Lin, J.X.; Migone, T.S.; Tsang, M.; Friedmann, M.; Weatherbee, J.A.; Zhou, L.; Yamauchi, A.; Bloom, E.T.; Mietz, J.; John, S.; and et, a.l. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2, 331-339, 1995.
101. Shivdasani, R.A.; and Orkin, S.H. The transcriptional control of hematopoiesis. Blood 87, 4025-4039, 1996.
102. Gainsford, T.; Roberts, A.W.; Kimura, S.; Metcalf, D.; Dranoff, G.; Mulligan, R.C.; Begley, C.G.; Robb, L.; and Alexander, W.S. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production. Blood 91, 2745-2752, 1998.
103. Bunn, H.; Gu, J.; Huang, L.; and Park, J.W. Erythropoietin: a model system for studying oxygen-dependent gene regulation. J. Exp. Biol. 201, 1197-201, 1998.
104. Ihle, J.N.; Nosaka, T.; Thierfelder, W.; Quelle, F.W.; and Shimoda, K. Jaks and Stats in cytokine signaling. Stem Cells 15, 105-112, 1997.
105. Pellegrini, S.; and Dusanter-Fourt, I. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur. J. Biochem. 248, 615-633, 1997.
106. Ihle, J.N. Cytokine receptor signalling. Nature 377, 591-594, 1995.
107. Metcalf, D. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339, 27-30, 1989.
108. Ogawa, M. Differentiation and proliferation of hematopoietic stem cells. Blood 81, 2844-2853, 1993.
109. Metcalf, D. Lineage Commitment and Maturation in Hematopoietic Cells: The Case for Extrinsic Regulation. Blood 92, 345b-347, 1998.
110. Enver, T.; Heyworth, C.M.; and Dexter, T.M. Do Stem Cells Play Dice? Blood 92, 348-351, 1998.
111. Yancopoulos, G.D.; Klagsbrun, M.; and Folkman, J. Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border [comment]. Cell 93, 661-664, 1998.
112. Flanagan, J.G.; and Vanderhaeghen, P. The ephrins and Eph receptors in neural development. Annu. Rev. Neurosci. 21, 309-345, 1998.
113. Gearing, D.P.; and Bruce, A.G. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor. New. Biol. 4, 61-65, 1992.
114. Berardi, A.C.; Wang, A.L.; Levine, J.D.; Lopez, P.; and Scadden, D.T. Functional isolation and characterization of human hematopoietic stem cells. Science 267, 104-108, 1995.
115. McKinstry, W.J.; Li, C.L.; Rasko, J.E.; Nicola, N.A.; Johnson, G.R.; and Metcalf, D. Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood 89, 65-71, 1997.
116. Hu, M.; Krause, D.; Greaves, M.; Sharkis, S.; Dexter, M.; Heyworth, C.; and Enver, T. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev. 11, 774-785, 1997.
117. Solar, G.P.; Kerr, W.G.; Zeigler, F.C.; Hess, D.; Donahue, C.; de Sauvage, F.J.; and Eaton, D.L. Role of c-mpl in early hematopoiesis. Blood 92, 4-10, 1998.
118. Nishijima, I.; Nakahata, T.; Hirabayashi, Y.; Inoue, T.; Kurata, H.; Miyajima, A.; Hayashi, N.; Iwakura, Y.; Arai, K.; and Yokota, T. A human GM-CSF receptor expressed in transgenic mice stimulates proliferation and differentiation of hemopoietic progenitors to all lineages in response to human GM-CSF. Mol. Biol. Cell 6, 497-508, 1995.
119. Nishijima, I.; Nakahata, T.; Watanabe, S.; Tsuji, K.; Tanaka, I.; Hirabayashi, Y.; Inoue, T.; and Arai, K. Hematopoietic and lymphopoietic responses in human granulocyte- macrophage colony-stimulating factor (GM-CSF) receptor transgenic mice injected with human GM-CSF. Blood 90, 1031-1038, 1997.
120. Stoffel, R.; Ledermann, B.; de Sauvage, F.J.; and Skoda, R.C. Permissive role of mpl and GCSF-receptor in hematopoietic cell fate decisions in vivo. Blood 90, 123a (abstr. suppl. 1), 1997.
121. Socolovsky, M.; Lodish, H.F.; and Daley, G.Q. Control of hematopoietic differentiation: lack of specificity in signaling by cytokine receptors. Proc. Natl. Acad. Sci. U.S.A. 95, 6573-6575, 1998.
122. Liboi, E.; Carroll, M.; D'Andrea, A.D.; and Mathey-Prevot, B. Erythropoietin receptor signals both proliferation and erythroid-specific differentiation. Proc. Natl. Acad. Sci. U.S.A. 90, 11351-11355, 1993.
123. Pless, M.; Norga, K.; Carroll, M.; Heim, M.H.; D'Andrea, A.D.; and Mathey-Prevot, B. Receptors that induce erythroid differentiation of Ba/F3 cells: structural requirements and effect on STAT5 binding. Blood 89, 3175-3185, 1997.
124. Porteu, F.; Rouyez, M.C.; Cocault, L.; Benit, L.; Charon, M.; Picard, F.; Gisselbrecht, S.; Souyri, M.; and Dusanter-Fourt, I. Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: Evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin. Mol. Cell. Biol. 16, 2473-2482, 1996.
125. Metcalf, D. Lineage commitment in the progeny of murine hematopoietic preprogenitor cells: influence of thrombopoietin and interleukin 5 [In Process Citation]. Proc. Natl. Acad. Sci. U.S.A. 95, 6408-6412, 1998.
126. Rodig, S.J.; Meraz, M.A.; White, J.M.; Lampe, P.A.; Riley, J.K.; Arthur, C.D.; King, K.L.; Sheehan, K.C.; Yin, L.; Pennica, D.; Johnson, E.M., Jr.; and Schreiber, R.D. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93, 373-383, 1998.
127. Parganas, E.; Wang, D.; Stravopodis, D.; Topham, D.J.; Marine, J.C.; Teglund, S.; Vanin, E.F.; Bodner, S.; Colamonici, O.R.; van Deursen, J.M.; Grosveld, G.; and Ihle, J.N. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93, 385-395, 1998.
128. Neubauer, H.; Cumano, A.; Muller, M.; Wu, H.; Huffstadt, U.; and Pfeffer, K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 93, 397-409, 1998.
129. Russell, S.M.; Tayebi, N.; Nakajima, H.; Riedy, M.C.; Roberts, J.L.; Aman, M.J.; Migone, T.S.; Noguchi, M.; Markert, M.L.; Buckley, R.H.; O'Shea, J.J.; and Leonard, W.J. Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development. Science 270, 797-800, 1995.
130. Thomis, D.C.; Gurniak, C.B.; Tivol, E.; Sharpe, A.H.; and Berg, L.J. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270, 794-797, 1995.
131. Durbin, J.E.; Hackenmiller, R.; Simon, M.C.; and Levy, D.E. Targeted disruption of the mouse STAT1 results in compromised innate immunity to viral disease. Cell 84, 443-450, 1996.
132. Meraz, M.A.; White, J.M.; Sheehan, K.; Bach, E.A.; Rodig, S.J.; Dighe, A.S.; Kaplan, D.H.; Riley, J.K.; Greenlund, A.C.; Campbell, D.; Carver, M.K.; DuBois, R.N.; Clark, R.; Aguet, M.; and Schreiber, R.D. Targeted disruption of the STAT1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442, 1996.
133. Takeda, K.; Noguchi, K.; Shi, W.; Tanaka, T.; Matsumoto, M.; Yoshida, N.; Kishimoto, T.; and Akira, S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. U.S.A. 94, 3801-3804, 1997.
134. Thierfelder, W.E.; van Deursen, J.M.; Yamamoto, K.; Tripp, R.A.; Sarawar, S.R.; Carson, R.T.; Sangster, M.Y.; Vignali, D.A.A.; Doherty, P.C.; Grosveld, G.C.; and Ihle, J.N. Requirement for STAT4 in interleukin-12-mediated responses of natural killer cells. Nature 382, 171-174, 1996.
135. Kaplan, M.H.; Schindler, U.; Smiley, S.T.; and Grusby, M.J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174-177, 1996.
136. Liu, X.; Robinson, G.W.; Wagner, K.U.; Garrett, L.; Wynshaw-Boris, A.; and Hennighausen, L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11, 179-186, 1997.
137. Udy, G.B.; Towers, R.P.; Snell, R.G.; Wilkins, R.J.; Park, S.H.; Ram, P.A.; Waxman, D.J.; and Davey, H.W. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. U.S.A. 94, 7239-7244, 1997.
138. Teglund, S.; McKay, C.; Schuetz, E.; van Deursen, J.M.; Stravopodis, D.; Wang, D.; Brown, M.; Bodner, S.; Grosveld, G.; and Ihle, J.N. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93, 841-850, 1998.
139. Takeda, K.; Tanaka, T.; Shi, W.; Matsumoto, M.; Minami, M.; Kashiwamura, S.; Nakanishi, K.; Yoshida, N.; Kishimoto, T.; and Akira, S. Essential role of Stat6 in IL-4 signalling. Nature 380, 627-630, 1996.
140. Kaplan, M.H.; Schindler, U.; Smiley, S.T.; and Grusby, M.J. Stat6 is required for mediating responses to I1-4 and for the development of Th2 cells. Immunity 4, 313-319, 1996.
141. Damen, J.E.; Wakao, H.; Miyajima, A.; Krosl, J.; Humphries, R.K.; Cutler, R.L.; and Krystal, G. Tyrosine 343 in the erytnropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14, 5557-5568, 1995.
142. Wu, H.; Klingmuller, U.; Besmer, P.; and Lodish, H.F. Interaction of the erythropoietin and stem-cell-factor receptors. Nature 377, 242-246, 1995.
143. Ghilardi, N.; and Skoda, R.C. The leptin receptor activates Janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol. Endocrino.1 11, 393-399, 1997.
144. Chiba, T.; Nagata, Y.; Kishi, A.; Sakamaki, K.; Miyajima, A.; Yamamoto, M.; Engel, J.D.; and Todokoro, K. Induction of erythroid-specific gene expression in lymphoid cells. Proc. Natl. Acad. Sci. U.S.A. 90, 11593-11597, 1993.
145. Jubinsky, P.T.; Nathan, D.G.; Wilson, D.J.; and Sieff, C.A. A low-affinity human granulocyte-macrophage colony-stimulating factor/murine erythropoietin hybrid receptor functions in murine cell lines. Blood 81, 587-591, 1993.
146. Fukunaga, R.; Ishizaka-Ikeda, E.; and Nagata, S. Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor. Cell 74, 1079-1087, 1993.
147. Dubart, A.; Feger, F.; Lacout, C.; Goncalves, F.; Vainchenker, W.; and Dumenil, D. Murine pluripotent hematopoietic progenitors constitutively expressing a normal erythropoietin receptor proliferate in response to erythropoietin without preferential erythroid cell differentiation. Mol. Cell Biol. 14, 4834-4842, 1994.
148. McArthur, G.A.; Metcalf, D.; Rakar, S.; and Johnson, G.R. Overexpression of c-FMS in the myeloid cell line FDC-P1 induces transformation that dissociates M-CSF-induced proliferation and differentiation. Leukemia 9, 68-76, 1995.
149. Just, U.; Katsuno, M.; Stocking, C.; Spooncer, E.; and Dexter, M. Targeted in vivo infection with a retroviral vector carrying the interleukin-3 (multi-CSF) gene leads to immortalization and leukemic transformation of primitive hematopoietic progenitor cells. Growth Factors 9, 41-55, 1993.
150. Fairbairn, L.J.; Cowling, G.J.; Reipert, B.M.; and Dexter, T.M. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74, 823-832, 1993.
151. Dong, F.; van Buitenen, C.; Pouwels, K.; Hoefsloot, L.H.; Lowenberg, B.; and Touw, I.P. Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol. Cell. Biol. 13, 7774-7781, 1993.
152. Borzillo, G.V.; Ashmun, R.A.; and Sherr, C.J. Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes. Mol. Cell. Biol. 10, 2703-2714, 1990.
153. Alexander, W.S.; Maurer, A.B.; Novak, U.; and Harrison-Sraith, M. Tyrosine-599 of the c-Mpl receptor is required for She phosphorylation and the induction of cellular differentiation. EMBO J. 15, 6531-6540, 1996.
154. Smith, A.; Metcalf, D.; and Nicola, N.A. Cytoplasmic domains of the common beta-chain of the GM-CSF/IL-3/IL-5 receptors that are required for inducing differentiation or clonal suppression in myeloid leukaemic cell lines. EMBO J. 16, 451-464, 1997.
155. Gearing, D.P.; Gough, N.M.; King, J.A.; Hilton, D.J.; Nicola, N.A.; Simpson, R.J.; Nice, E.C.; Kelso, A.; and Metcalf, D. Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J. 6, 3995-4002, 1987.
156. Goncalves, F.; Lacout, C.; Villeval, J.L.; Wendling, F.; Vainchenker, W.; and Dumenil, D. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation. Blood 89, 3544-3553, 1997.
157. Cocault, L.; Bouscary, D.; Kerdiles, C.L.; Clay, D.; Picard, F.; Gisselbrecht, S.; and Souyri, M. Ectopic expression of murine TPO receptor (c-mpl) in mice is pathogenic and induces erythroblastic proliferation. Blood 88, 1656-1665, 1996.
158. Pharr, P.N.; Ogawa, M.; Hofbauer, A.; and Longmore, G.D. Expression of an activated erythropoietin or a colony-stimulating factor 1 receptor by pluripotent progenitors enhances colony formation but does not induce differentiation. Proc. Natl. Acad. Sci. U.S.A. 91, 7482-7486, 1994.
159. McArthur, G.A.; Rohrschneider, L.R.; and Johnson, G.R. Induced expression of c-fms in normal hematopoietic cells shows evidence for both conservation and lineage restriction of signal transduction in response to macrophage colony-stimulating factor. Blood 83, 972-981, 1994.
160. McArthur, G.A.; Longmore, G.D.; Klingler, K.; and Johnson, G.R. Lineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoR. Exp. Hematol. 23, 645-654, 1995.
161. Socolovsky, M.; Dusanter-Fourt, I.; and Lodish, H.F. The prolactin receptor and severely truncated erythropoietin receptors support differentiation of erythroid progenitors. J. Biol. Chem. 272, 14009-14012, 1997.
162. Jacob, J.; Haug, J.S.; Raptis, S.; and Link, D.C. Specific Signals Generated by the Cytoplasmic Domain of the Granulocyte Colony-Stimulating Factor (G-CSF) Receptor Are Not Required for G-CSF-Dependent Granulocytic Differentiation. Blood 92, 353-361, 1998.
163. Goldsmith, M.A.; Mikami, A.; You, Y.; Liu, K.D.; Thomas, L.; Pharr, P.; and Longmore, G.D. Absence of cytokine receptor-dependent specificity in red blood cell differentiation in vivo. Proc. Natl. Acad. Sci. U.S.A. 95, 7006-7011, 1998.